Insurers testing exotics for Solvency II optimisation

With just weeks to go until Solvency II comes into force at the start of 2016, European insurers have been turning to complex equity derivatives in a bid to manage their capital more efficiently. But with continuing uncertainty surrounding some of the finer details of the regulation and a lack of clarity over exactly what constitutes excessive basis risk, both dealers and insurers have to make